Legend Biotech Co. (NASDAQ:LEGN) Receives $79.00 Average PT from Analysts
Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve brokerages that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a hold rating and eleven have given a buy rating to the company. The average 12-month target price among brokerages […]
Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve brokerages that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a hold rating and eleven have given a buy rating to the company. The average 12-month target price among brokerages […]
